Silencing of IL13RA2 promotes partial epithelial‐mesenchymal transition in hepatocellular carcinoma via ERK signaling pathway activation
Mimi Wang(Fudan University), Yanhong Wang(Xuzhou Medical College)
Cited by 6
Related Papers
Phosphorylated ERK is a potential predictor of sensitivity to sorafenib when treating hepatocellular carcinoma: evidence from an in vitrostudy
|BMC Medicine|2009|147
Schedule-dependent antitumor effects of 5-fluorouracil combined with sorafenib in hepatocellular carcinoma
|BMC Cancer|2013|21
Metabolic enzyme PFKFB3 mediates matrix stiffness‐potentiated tumour growth and radiotherapeutic resistance in HCC
|Clinical and Translational Medicine|2025|0